Fernando Cotait Maluf

780 total citations
38 papers, 368 citations indexed

About

Fernando Cotait Maluf is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Fernando Cotait Maluf has authored 38 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 9 papers in Obstetrics and Gynecology. Recurrent topics in Fernando Cotait Maluf's work include Prostate Cancer Treatment and Research (10 papers), Ovarian cancer diagnosis and treatment (7 papers) and Uterine Myomas and Treatments (7 papers). Fernando Cotait Maluf is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Ovarian cancer diagnosis and treatment (7 papers) and Uterine Myomas and Treatments (7 papers). Fernando Cotait Maluf collaborates with scholars based in Brazil, United States and Italy. Fernando Cotait Maluf's co-authors include Paul Sabbatini, Carol Aghajanian, Lawrence Schwartz, Òren Smaletz, Daniel Herchenhorn, Lisa M. DeAngelis, Lauren E. Abrey, Jeffrey J. Raizer, Filomena Marino Carvalho and Aliza Leiser and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Fernando Cotait Maluf

36 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernando Cotait Maluf Brazil	11	140	112	107	93	70	38	368
Toshinari Muramatsu Japan	11	46 0.3×	68 0.6×	97 0.9×	102 1.1×	100 1.4×	42	363
Viorica Nagy Romania	14	202 1.4×	70 0.6×	189 1.8×	32 0.3×	73 1.0×	30	390
Adela Poitevin Mexico	8	54 0.4×	136 1.2×	153 1.4×	45 0.5×	94 1.3×	11	406
C O'Flaherty United States	6	90 0.6×	57 0.5×	187 1.7×	149 1.6×	127 1.8×	8	430
A. Bamias Greece	11	120 0.9×	65 0.6×	226 2.1×	184 2.0×	207 3.0×	28	559
Ana T. Nunes United States	11	70 0.5×	78 0.7×	275 2.6×	52 0.6×	120 1.7×	19	455
Josep M. del Campo Spain	10	78 0.6×	79 0.7×	187 1.7×	261 2.8×	131 1.9×	20	439
Thomas Hendrik Knocke Austria	9	59 0.4×	172 1.5×	69 0.6×	76 0.8×	85 1.2×	12	364
Sonia Yip Australia	14	361 2.6×	99 0.9×	308 2.9×	90 1.0×	84 1.2×	75	662
Joerg Schwarz Germany	11	97 0.7×	140 1.3×	124 1.2×	73 0.8×	111 1.6×	13	592

Countries citing papers authored by Fernando Cotait Maluf

Since Specialization

Citations

This map shows the geographic impact of Fernando Cotait Maluf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Cotait Maluf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Cotait Maluf more than expected).

Fields of papers citing papers by Fernando Cotait Maluf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Cotait Maluf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Cotait Maluf. The network helps show where Fernando Cotait Maluf may publish in the future.

Co-authorship network of co-authors of Fernando Cotait Maluf

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Cotait Maluf. A scholar is included among the top collaborators of Fernando Cotait Maluf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Cotait Maluf. Fernando Cotait Maluf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Melo, Andréia Cristina de, Angélica Nogueira‐Rodrigues, Mariana Scaranti, et al.. (2023). Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil. Frontiers in Oncology. 13. 1133277–1133277. 2 indexed citations

Maluf, Fernando Cotait, Karine Martins da Trindade, Daniel D’Almeida Preto, et al.. (2023). A phase II trial of pembrolizumab combined with platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.. Journal of Clinical Oncology. 41(6_suppl). TPS14–TPS14. 4 indexed citations

Fujiwara, Keiichi, Brian M. Slomovitz, Antonio González-Martı́n, et al.. (2023). 288MO InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer. Annals of Oncology. 34. S1586–S1586. 4 indexed citations

Wroclawski, Marcelo Langer, Erik Montagna, Bianca Bianco, et al.. (2022). Knowledge, attitudes, and practices of active surveillance in prostate cancer among urologists: a real-life survey from Brazil. BMC Urology. 22(1). 86–86.

Maluf, Fernando Cotait, Fabrício Augusto Martinelli de Oliveira, Pedro Emanuel Rubini Liedke, et al.. (2021). Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV Study. Clinical Genitourinary Cancer. 19(3). e171–e177. 1 indexed citations

Monteiro, Fernando Sabino Marques, Andrey Soares, Márcio Debiasi, et al.. (2020). First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis. Clinical Genitourinary Cancer. 18(4). 244–251.e4. 19 indexed citations

Molin, Graziela Zibetti Dal, et al.. (2019). Risk of fatigue and anemia in patients with advanced cancer treated with olaparib: A meta-analysis of randomized controlled trials. Critical Reviews in Oncology/Hematology. 141. 163–173. 41 indexed citations

Werutsky, Gustavo, Fernando Cotait Maluf, Eduardo Cronemberger, et al.. (2019). The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels. BMC Cancer. 19(1). 487–487. 10 indexed citations

Moreira, Raphael Brandão, Márcio Debiasi, Fernando Cotait Maluf, et al.. (2016). Differential side effects profile in mCRPC patients treated with abiraterone or enzalutamide: A meta-analysis of randomized controlled trials.. Journal of Clinical Oncology. 34(2_suppl). 73–73. 5 indexed citations

10.

Smaletz, Òren, Maria Del Pilar Estevez-Diz, Jorge Sabbaga, et al.. (2015). A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma. Gynecologic Oncology. 138(2). 272–277. 22 indexed citations

11.

Carvalho, Filomena Marino, et al.. (2015). Uterine tumors resembling ovarian sex-cord tumor: A case-report and a review of literature. SHILAP Revista de lepidopterología. 15. 22–24. 15 indexed citations

12.

Moreira, Raphael Brandão, et al.. (2015). Next-generation sequencing (NGS) in metastatic breast cancer (mBC) patients: Translation from sequence data into clinical practice.. Journal of Clinical Oncology. 33(28_suppl). 133–133. 4 indexed citations

13.

Maluf, Fernando Cotait, et al.. (2014). Vencer o câncer. 512–512. 1 indexed citations

14.

Smaletz, Òren, Maria Del Pilar Estevez-Diz, Jorge Sabbaga, et al.. (2011). Anti-LeY monoclonal antibody (mAb) hu3S193 (Rebmab 100) in patients with advanced platinum resistant/refractory (PRR) ovarian cancer (OC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC).. Journal of Clinical Oncology. 29(15_suppl). 5078–5078. 3 indexed citations

15.

Gallagher, David, Matthew I. Milowsky, Alexia Iasonos, et al.. (2009). Sequential adjuvant chemotherapy after surgical resection of high‐risk urothelial carcinoma. Cancer. 115(22). 5193–5201. 9 indexed citations

16.

Maluf, Fernando Cotait, Gustavo dos Santos Fernandes, Ariel Galapo Kann, et al.. (2008). Exploring the role of novel agents in the treatment of renal cell carcinoma. Cancer Treatment Reviews. 34(8). 750–760. 5 indexed citations

17.

Leiser, Aliza, Fernando Cotait Maluf, D. S., et al.. (2007). A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer. International Journal of Gynecological Cancer. 17(2). 379–386. 13 indexed citations

18.

Maluf, Fernando Cotait, Aliza Leiser, Carol Aghajanian, et al.. (2006). Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. International Journal of Gynecological Cancer. 16(3). 1165–1171. 27 indexed citations

19.

Dizon, Don S., Fernando Cotait Maluf, Carol Aghajanian, et al.. (2001). Phase I study of ZD0473 and liposomal doxorubicin in advanced refractory solid tumor malignancies. European Journal of Cancer. 37. S77–S77. 3 indexed citations

20.

Maluf, Fernando Cotait, et al.. (2001). Endometrial Stromal Sarcoma: Objective Response to Letrozole. Gynecologic Oncology. 82(2). 384–388. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact